Ginkgo Bioworks Holdings Inc vs SoundHound AI Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.08 (market cap $590.53M), while SoundHound AI Inc trades at $6.46 (market cap $2.91B). The key difference: SoundHound AI Inc is far larger — about 4.9× Ginkgo Bioworks Holdings Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals.
| DNA | SOUN | |
|---|---|---|
Market Cap | $590.53M | $2.91B |
Sector | Health | Technology |
52-Week High | $16.14 | $21.40 |
52-Week Low | $5.48 | $5.90 |
Enterprise Value | $627.78M | $2.71B |
Signals from Pluang's Aura AI — not financial advice
DNA trades at $9.05, down 0.44% on the day, reflecting ongoing investor caution. The technical outlook is bearish, while fundamentals show significant losses with a net income margin of -201.05% and negative cash flows. Recent earnings have been mixed, missing estimates in two of the last three quarters. Analyst sentiment is divided, with a slight lean toward buy ratings amid high volatility and operational challenges.
The outlook remains challenging due to persistent losses and cash burn, though analyst coverage suggests potential long-term value. Key risks include execution missteps and intense competition in biotechnology. Investment appeal hinges on future profitability improvements and successful business model execution.
SoundHound AI (SOUN) trades at $6.49, down 2.26% on the day and 37% year-to-date, reflecting investor concerns over persistent losses despite strong revenue growth. The stock shows a bearish technical trend with neutral oscillators, while fundamentals reveal a high P/S of 15.03 and negative net income margin of -91.84%. Recent positive developments include being named a Leader in Gartner's Magic Quadrant for Conversational AI Platforms (GlobeNewsWire, July 13, 2026) and beating EPS estimates in three consecutive quarters.
The outlook remains high-risk with significant cash burn and execution challenges, but analyst consensus is bullish with a $13 price target (75% buy ratings). Investment opportunity hinges on successful integration of acquisitions like LivePerson and expansion into telecom/energy markets, though volatility from short interest and profitability concerns pose substantial downside risk.
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →